Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Three High Growth Companies With Significant Insider Ownership

In This Article:

As global markets grapple with the uncertainties surrounding the incoming Trump administration's policies, investors are keenly observing how these developments might impact various sectors, particularly those sensitive to regulatory changes. Amidst this backdrop of fluctuating indices and sector-specific volatility, identifying growth companies with significant insider ownership can provide insights into potential investment opportunities. In such a dynamic environment, stocks where insiders have substantial stakes may indicate confidence in the company's long-term prospects and resilience against market shifts.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Seojin SystemLtd (KOSDAQ:A178320)

31.1%

52.4%

On Holding (NYSE:ONON)

19.1%

29.7%

Pharma Mar (BME:PHM)

11.8%

56.9%

Medley (TSE:4480)

34%

31.7%

Findi (ASX:FND)

34.8%

71.5%

Elliptic Laboratories (OB:ELABS)

26.8%

103.6%

Plenti Group (ASX:PLT)

12.8%

120.1%

Credo Technology Group Holding (NasdaqGS:CRDO)

13.8%

95%

Alkami Technology (NasdaqGS:ALKT)

11%

98.6%

Brightstar Resources (ASX:BTR)

16.2%

84.6%

Click here to see the full list of 1530 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

Apollo Hospitals Enterprise

Simply Wall St Growth Rating: ★★★★★☆

Overview: Apollo Hospitals Enterprise Limited, along with its subsidiaries, provides healthcare services in India and internationally with a market cap of ₹969.47 billion.

Operations: The company's revenue segments include Healthcare Services at ₹106.37 billion, Retail Health & Diagnostics at ₹14.61 billion, and Digital Health & Pharmacy Distribution at ₹84.40 billion.

Insider Ownership: 10.4%

Earnings Growth Forecast: 30.7% p.a.

Apollo Hospitals Enterprise demonstrates robust growth potential with its earnings expected to increase significantly at 30.7% annually, outpacing the Indian market's 18%. Recent Q2 results show impressive revenue and net income growth, reflecting strong operational performance. The company's strategic expansions in Mumbai and Lucknow aim to enhance capacity, funded through internal accruals and debt. Despite no recent insider trading activity, high insider ownership aligns interests with shareholders, supporting long-term value creation.

NSEI:APOLLOHOSP Earnings and Revenue Growth as at Nov 2024
NSEI:APOLLOHOSP Earnings and Revenue Growth as at Nov 2024

Shanghai OPM Biosciences

Simply Wall St Growth Rating: ★★★★★☆